AU2021320763A1 - Compositions for modulating splicing - Google Patents
Compositions for modulating splicing Download PDFInfo
- Publication number
- AU2021320763A1 AU2021320763A1 AU2021320763A AU2021320763A AU2021320763A1 AU 2021320763 A1 AU2021320763 A1 AU 2021320763A1 AU 2021320763 A AU2021320763 A AU 2021320763A AU 2021320763 A AU2021320763 A AU 2021320763A AU 2021320763 A1 AU2021320763 A1 AU 2021320763A1
- Authority
- AU
- Australia
- Prior art keywords
- compound
- formula
- methyl
- fluoro
- mmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063061742P | 2020-08-05 | 2020-08-05 | |
| US63/061,742 | 2020-08-05 | ||
| PCT/US2021/044528 WO2022031838A1 (en) | 2020-08-05 | 2021-08-04 | Compositions for modulating splicing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2021320763A1 true AU2021320763A1 (en) | 2023-03-30 |
Family
ID=80117649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2021320763A Pending AU2021320763A1 (en) | 2020-08-05 | 2021-08-04 | Compositions for modulating splicing |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230331718A1 (https=) |
| EP (1) | EP4192454B1 (https=) |
| JP (1) | JP2023538524A (https=) |
| KR (1) | KR20230048106A (https=) |
| CN (1) | CN116171153B (https=) |
| AR (1) | AR123150A1 (https=) |
| AU (1) | AU2021320763A1 (https=) |
| CA (1) | CA3188104A1 (https=) |
| IL (1) | IL300352A (https=) |
| MX (1) | MX2023001558A (https=) |
| TW (1) | TW202216697A (https=) |
| UY (1) | UY39368A (https=) |
| WO (1) | WO2022031838A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020163248A1 (en) | 2019-02-04 | 2020-08-13 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
| EP3920915A4 (en) * | 2019-02-05 | 2022-10-05 | Skyhawk Therapeutics, Inc. | METHODS AND COMPOSITIONS FOR MODULATING SPLICE |
| CN114126613A (zh) | 2019-02-05 | 2022-03-01 | 斯基霍克疗法公司 | 用于调节剪接的方法和组合物 |
| WO2020163544A1 (en) | 2019-02-06 | 2020-08-13 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
| CN113661162A (zh) | 2019-02-06 | 2021-11-16 | 斯基霍克疗法公司 | 用于调节剪接的方法和组合物 |
| GB202106871D0 (en) * | 2021-05-13 | 2021-06-30 | Addex Pharmaceuticals Sa | Novel compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2579949T3 (es) | 2010-02-05 | 2016-08-17 | Heptares Therapeutics Limited | Derivados de 1,2,4-triazin-4-amina |
| WO2019028440A1 (en) | 2017-08-04 | 2019-02-07 | Skyhawk Therapeutics, Inc. | METHODS AND COMPOSITIONS FOR MODULATING SPLICING |
| MX2020009957A (es) | 2018-03-27 | 2021-01-15 | Ptc Therapeutics Inc | Compuestos para el tratamiento de enfermedad de hungtinton. |
| CN112272666A (zh) | 2018-04-10 | 2021-01-26 | 斯基霍克疗法公司 | 用于治疗癌症的化合物 |
| WO2020163248A1 (en) * | 2019-02-04 | 2020-08-13 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
| EP3920915A4 (en) * | 2019-02-05 | 2022-10-05 | Skyhawk Therapeutics, Inc. | METHODS AND COMPOSITIONS FOR MODULATING SPLICE |
| EP3920918A4 (en) * | 2019-02-05 | 2022-11-16 | Skyhawk Therapeutics, Inc. | METHODS AND COMPOSITIONS FOR MODULATION OF SPLICING |
| WO2022031998A2 (en) | 2020-08-05 | 2022-02-10 | Skyhawk Therapeutics, Inc. | Process for the preparation of intermediates useful in the preparation of compounds that modulate splicing |
-
2021
- 2021-08-04 EP EP21852740.6A patent/EP4192454B1/en active Active
- 2021-08-04 AU AU2021320763A patent/AU2021320763A1/en active Pending
- 2021-08-04 UY UY0001039368A patent/UY39368A/es not_active Application Discontinuation
- 2021-08-04 KR KR1020237007640A patent/KR20230048106A/ko active Pending
- 2021-08-04 JP JP2023508065A patent/JP2023538524A/ja active Pending
- 2021-08-04 AR ARP210102177A patent/AR123150A1/es unknown
- 2021-08-04 TW TW110128712A patent/TW202216697A/zh unknown
- 2021-08-04 IL IL300352A patent/IL300352A/en unknown
- 2021-08-04 CA CA3188104A patent/CA3188104A1/en active Pending
- 2021-08-04 WO PCT/US2021/044528 patent/WO2022031838A1/en not_active Ceased
- 2021-08-04 MX MX2023001558A patent/MX2023001558A/es unknown
- 2021-08-04 CN CN202180062419.8A patent/CN116171153B/zh active Active
-
2023
- 2023-01-31 US US18/162,085 patent/US20230331718A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AR123150A1 (es) | 2022-11-02 |
| IL300352A (en) | 2023-04-01 |
| CN116171153A (zh) | 2023-05-26 |
| US20230331718A1 (en) | 2023-10-19 |
| WO2022031838A1 (en) | 2022-02-10 |
| CN116171153B (zh) | 2025-11-21 |
| EP4192454A4 (en) | 2024-09-11 |
| EP4192454A1 (en) | 2023-06-14 |
| TW202216697A (zh) | 2022-05-01 |
| CA3188104A1 (en) | 2022-02-10 |
| UY39368A (es) | 2022-01-31 |
| JP2023538524A (ja) | 2023-09-08 |
| KR20230048106A (ko) | 2023-04-10 |
| MX2023001558A (es) | 2023-04-26 |
| EP4192454B1 (en) | 2026-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4192454B1 (en) | Azabicyclo-amino-triazine compounds for modulating splicing for the treatment of neurological diseases | |
| US10138249B2 (en) | Triazolopyridines and triazolopyrazines as LSD1 inhibitors | |
| WO2022060951A1 (en) | Compositions for modulating splicing | |
| US20200024277A1 (en) | Triazolopyridines and triazolopyrazines as lsd1 inhibitors | |
| MX2008011257A (es) | Derivados de quinolina e isoquinolina como inhibidores de fosfodiesterasa 10. | |
| JP2018508555A (ja) | 二環性イミダゾロ誘導体 | |
| WO2022060943A1 (en) | Compositions for modulating splicing | |
| WO2023081860A1 (en) | Triazine amino derivatives for treating sca3 | |
| JP2023544653A (ja) | 複素環置換の縮合γ－カルボリン誘導体、その製造方法、中間体及び使用 | |
| JP2018076285A (ja) | 二環性イミダゾロ誘導体を含む医薬 | |
| WO2022060944A1 (en) | Compositions for modulating splicing | |
| WO2024155846A1 (en) | Compositions useful for modulating splicing | |
| EP4651950A1 (en) | Compositions useful for modulating splicing | |
| CN111747927B (zh) | 作为免疫调节剂的化合物及其应用 | |
| CN117024441A (zh) | 一种mat2a抑制剂 | |
| WO2026019893A1 (en) | Compositions useful for modulating splicing | |
| WO2026019914A1 (en) | Compositions useful for modulating splicing | |
| EP4522624A1 (en) | Compositions useful for modulating splicing | |
| WO2023212231A1 (en) | Compositions useful for modulating splicing | |
| CN119403802A (zh) | 二并环类mat2a抑制剂及其用途 | |
| CN118852164A (zh) | Parp选择性抑制剂 |